Medical Discovery News
Science permeates everyday life. Yet the understanding of advances in biomedical science is limited at best. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today for the medicine of tomorrow. Our weekly five-hundred-word newspaper column (http://www.illuminascicom.com/) and two-minute radio show provide insights into a broad range of biomedical science topics. Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine. Each release is designed to stimulate listeners to think, question and appreciate how science affects their health as well as that of the rest of the world. We also delve into significant biomedical discoveries and portray how science (or the lack of it) has impacted health throughout history.
Medical Discovery News
AI as a Tool for New Therapeutics
AI Tool for New Therapeutics
Welcome to Medical Discovery News. I’m Dr. Norbert Herzog.
And I’m Dr. David Niesel
In medicine, artificial intelligence is already being used in a variety of ways…it is being used to screen tissues and images for cancer cells.
Now AI may help us come up with better drugs and vaccines, specifically mRNA vaccines which is the same technology behind two COVID vaccines.
Researchers used AI to design the structure enhancing the stability of the mRNAs. The goal was to make the mRNA more stable once injected in the body so that it will trigger the immune system to make higher amounts of protective antibodies.
These AI engineered mRNA are double stranded molecules that produce more than one hundred times the antibody response than non-AI optimized mRNAs.
The shelf life is also longer. And the same approach could be used to design vaccines for a wide range of diseases including ones that fight cancer.
In another separate study, AI networks were trained on databases with thousands of protein sequences to create antibodies that bind to their targets better. This led to some antibodies that were better at binding to SARS-CoV2, Ebola and the flu virus.
That means that they’re more efficient at helping the immune system launch a robust defense against these threatening diseases.
Scientists now speculate this generative AI approach can go beyond improving existing antibodies to design new ones to fight deadly viruses. That would be helpful in dealing with a future that’s bound to include unpredictable pandemics.
We are Drs. David Niesel and Norbert Herzog, at UTMB and Quinnipiac University, where biomedical discoveries shape the future of medicine. For much more and our disclaimer go to medicaldiscoverynews.com or subscribe to our podcast. Sign up for expanded print episodes at www.illuminascicom.com
